AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34481702 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm E (IPV at 6 and 14-weeks)
Number of subjects: 936
Study 33895382 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeon's knot (Revo knot)
Number of subjects: 10
Study 33895382 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicky knot
Number of subjects: 10
Study 33895382 — intervention group
Group type: EXPERIMENTAL
Intervention: All knots evaluated
Number of subjects: 10
Study 33895382 — intervention group
Group type: EXPERIMENTAL
Intervention: Duncan loop, Tennessee slider, Nicky knot, SMC knot
Number of subjects: 10
Study 33215284 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa monotherapy
Number of subjects: 540
Study 33215284 — intervention group
Group type: COMPARATOR
Intervention: No levodopa treatment strategies
Number of subjects: 540
Study 33215284 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa with other medications
Number of subjects: 540
Study 35075087 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT) in combination with standard rehabilitation protocol
Number of subjects: 52
Study 35075087 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation protocol (Control)
Number of subjects: 52
Study 33270098 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine plus Irinotecan (CAPIRI)
Number of subjects: 98
Study 33270098 — intervention group
Group type: COMPARATOR
Intervention: Irinotecan (IRI) alone
Number of subjects: 98
Study 34129953 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification intervention with social incentives (participants receive a Fitbit Inspire 2 and select a daily step goal, enrolled in a game with loss-framed points and levels)
Number of subjects: 0
Study 34129953 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification intervention
Number of subjects: 0
Study 34129953 — intervention group
Group type: COMPARATOR
Intervention: Control group (participants receive a Fitbit Inspire 2 and select a daily step goal without gamification)
Number of subjects: 0
Study 34802002 — intervention group
Group type: EXPERIMENTAL
Intervention: UControlDrink smartphone app (UCD) with treatment as usual (TAU)
Number of subjects: 111
Study 34802002 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 111
Study 33660312 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimum utilization of child health record book
Number of subjects: 450
Study 33660312 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading all sections of the book
Number of subjects: 450
Study 33660312 — intervention group
Group type: EXPERIMENTAL
Intervention: Recording comments in the book
Number of subjects: 450
Study 33660312 — intervention group
Group type: EXPERIMENTAL
Intervention: Older parents age
Number of subjects: 450
Study 33660312 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher education attainment
Number of subjects: 450
Study 33660312 — intervention group
Group type: EXPERIMENTAL
Intervention: Good level of knowledge on child health record books
Number of subjects: 450
Study 33660312 — intervention group
Group type: EXPERIMENTAL
Intervention: Good level of knowledge on general child health
Number of subjects: 450
Study 33660312 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivering children in government hospitals
Number of subjects: 450
Study 34115909 — intervention group
Group type: EXPERIMENTAL
Intervention: RVNEW equation for predicting underwater residual lung volume
Number of subjects: 175
Study 34115909 — intervention group
Group type: COMPARATOR
Intervention: Existing RV equations
Number of subjects: 175
Study 34115909 — intervention group
Group type: EXPERIMENTAL
Intervention: RVNEW equation for calculating underwater %BF
Number of subjects: 175
Study 34115909 — intervention group
Group type: COMPARATOR
Intervention: Existing equations for calculating underwater %BF
Number of subjects: 175
Study 33047550 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention1 (routine preoperative counseling + usual admission)
Number of subjects: 90
Study 33047550 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention2 (routine preoperative counseling + admission by counselor)
Number of subjects: 90
Study 33047550 — intervention group
Group type: COMPARATOR
Intervention: Control (routine preoperative counseling + usual admission)
Number of subjects: 90
Study 33047550 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Intervention1, Intervention2, Control)
Number of subjects: 90
Study 35095034 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling every other month for one year
Number of subjects: 19
Study 34640468 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) group therapy
Number of subjects: 26
Study 34640468 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (WL) group
Number of subjects: 26
Study 32838679 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First with Assertive Community Treatment (ACT)
Number of subjects: 950
Study 32838679 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 950
Study 35927828 — intervention group
Group type: COMPARATOR
Intervention: Syrup placebo
Number of subjects: 161
Study 33620321 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth program for 6 months
Number of subjects: 478
Study 33620321 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting-list)
Number of subjects: 478
Study 32819681 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous metoprolol (up to 15 mg) before primary percutaneous coronary intervention
Number of subjects: 270
Study 32819681 — intervention group
Group type: COMPARATOR
Intervention: Conventional STEMI therapy
Number of subjects: 270
Study 32819681 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired LV global circumferential strain (GCS)
Number of subjects: 270
Study 32819681 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired LV global longitudinal strain (GLS)
Number of subjects: 270
Study 32819681 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intravenous metoprolol in patients with GLS ≥ -11.5%
Number of subjects: 270
Study 35620570 — intervention group
Group type: EXPERIMENTAL
Intervention: empagliflozin‐metformin combination (25 mg and 2000 mg daily)
Number of subjects: 40
Study 33910945 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary combined clinic intervention
Number of subjects: 300
Study 33910945 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study 33278022 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) infusion
Number of subjects: 150
Study 33278022 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 150
Study 34963404 — intervention group
Group type: EXPERIMENTAL
Intervention: Position Specific Physiotherapy Training (4 weeks)
Number of subjects: 30
Study 34930299 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in number of steps
Number of subjects: 707
Study 34930299 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary factors (less alcohol, fatty and sugary food, more fruit and vegetables)
Number of subjects: 707
Study 34930299 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatty food score
Number of subjects: 707
Study 34930299 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugary food score
Number of subjects: 707
Study 34930299 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in weight
Number of subjects: 707
Study 34930299 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline values and change in weight
Number of subjects: 707
Study 34930299 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in body weight
Number of subjects: 707
Study 33678716 — intervention group
Group type: EXPERIMENTAL
Intervention: Configurational priming in DHH participants
Number of subjects: 0
Study 33678716 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonological priming in DHH participants
Number of subjects: 0
Study 33678716 — intervention group
Group type: COMPARATOR
Intervention: Hearing participants
Number of subjects: 0
Study 33678716 — intervention group
Group type: EXPERIMENTAL
Intervention: DHH participants
Number of subjects: 0
Study 32277872 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium bifidum HI-MIMBb75 (1×10^9 non-viable cells, taken orally once a day for 8 weeks)
Number of subjects: 443
Study 32277872 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two capsules taken orally once a day for 8 weeks)
Number of subjects: 443
Study 32277872 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium bifidum HI-MIMBb75
Number of subjects: 443
Study 32277872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 443
Study 35236137 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompting
Number of subjects: 15
Study 35236137 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management
Number of subjects: 15
Study 35236137 — intervention group
Group type: EXPERIMENTAL
Intervention: Breaks
Number of subjects: 15
Study 35236137 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory proprioception
Number of subjects: 15
Study 34615893 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 56
Study 34615893 — intervention group
Group type: COMPARATOR
Intervention: Waiting group (control)
Number of subjects: 56
Study 32286644 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive therapy (valganciclovir, 900 mg, twice daily until 2 consecutive negative tests a week apart for 100 days)
Number of subjects: 205
Study 35354778 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation (PTNS)
Number of subjects: 166
Study 35354778 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 166
Study 35354778 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition-specific quality of life measures
Number of subjects: 166
Study 35354778 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious adverse events
Number of subjects: 166
Study 33549516 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS to the left dorsolateral prefrontal cortex
Number of subjects: 40
Study 33549516 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 40
Study 33549516 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS to the right dorsolateral prefrontal cortex
Number of subjects: 40
Study 32877155 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 72
Study 32877155 — intervention group
Group type: COMPARATOR
Intervention: Conventional osteotomy
Number of subjects: 72
Study 33814199 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptinezumab 100 mg
Number of subjects: 501
Study 33814199 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptinezumab 300 mg
Number of subjects: 501
Study 33814199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 501
Study 34266308 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 1242
Study 34266308 — intervention group
Group type: COMPARATOR
Intervention: Control (no EVT)
Number of subjects: 1242
Study 32246655 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer restorative system (Equia™)
Number of subjects: 30
Study 32246655 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk-fill composite (Sonicfill™)
Number of subjects: 30
Study 32246655 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk-fill composite (X‐tra fil™)
Number of subjects: 30
Study 32246655 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanohybrid composite (Filtek Z550™)
Number of subjects: 30
Study 33440447 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (a‐tDCS) over the primary motor cortex (M1)
Number of subjects: 24
Study 33440447 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 24
Study 616084013 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon Laser Peripheral Iridoplasty (ALPI)
Number of subjects: 22
Study 616084013 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 22
Study 35276031 — intervention group
Group type: EXPERIMENTAL
Intervention: bMBI (Brief Mindfulness-Based Intervention)
Number of subjects: 63
Study 35276031 — intervention group
Group type: COMPARATOR
Intervention: Standard medical treatment
Number of subjects: 63
Study 33243246 — intervention group
Group type: COMPARATOR
Intervention: Physically Active Learning (PAL) intervention: 30 min physically active learning, 30 min PA, and a 60 min physical education (PE) lesson per week.
Number of subjects: 2084
Study 33243246 — intervention group
Group type: COMPARATOR
Intervention: Don't worry-Be happy (DWBH) intervention: 60 min PA lesson and a 60 min PE lesson per week, tailored to promote friendships and wellbeing.
Number of subjects: 2084
Study 33243246 — intervention group
Group type: EXPERIMENTAL
Intervention: Control group: standard amount of mandatory PE lessons without additional interventions.
Number of subjects: 2084
Study 34896870 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Social Skills Training (CBSST)
Number of subjects: 63
Study 34896870 — intervention group
Group type: COMPARATOR
Intervention: Treatment‐As‐Usual (TAU)
Number of subjects: 63
Study 34984065 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive care plus colchicine
Number of subjects: 49
Study 34984065 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive care plus budesonide inhaler
Number of subjects: 49
Study 34984065 — intervention group
Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 49
Study 32426316 — intervention group
Group type: EXPERIMENTAL
Intervention: Group nutrition counseling (GNC)
Number of subjects: 74
Study 32426316 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutrition prescription (INP)
Number of subjects: 74
Study 32426316 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 74
Study 35838438 — intervention group
Group type: COMPARATOR
Intervention: Ketamine treatment in clinical trials (exact dosage and duration not specified)
Number of subjects: 380
Study 34914258 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Chamomile and Lidocaine Hydrochloride Gel
Number of subjects: 116
Study 34914258 — intervention group
Group type: COMPARATOR
Intervention: Primary Snodgrass urethroplasty only
Number of subjects: 116
Study 33714700 — intervention group
Group type: EXPERIMENTAL
Intervention: TPR technique (skin traction, pressure, rapid muscle release)
Number of subjects: 63
Study 33714700 — intervention group
Group type: COMPARATOR
Intervention: Z‐track injection method
Number of subjects: 63
Study 34738912 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital self-management program (HOPE)
Number of subjects: 61
Study 34738912 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (CG)
Number of subjects: 61
Study 32145441 — intervention group
Group type: EXPERIMENTAL
Intervention: LEAPS intervention (lay health worker support)
Number of subjects: 0
Study 33831770 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on yoga treatment
Number of subjects: 89
Study 33831770 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU - wait-list control)
Number of subjects: 89
Study 36107614 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (1.0 mg/kg bolus before intubation, continuous infusion during surgery, and 1.0 mg/kg bolus after surgery)
Number of subjects: 165
Study 36107614 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (1.0 mg/kg bolus before intubation, continuous infusion during surgery, and 1.0 mg/kg bolus after surgery) + Ramosetron (0.3 mg after surgery)
Number of subjects: 165
Study 36107614 — intervention group
Group type: COMPARATOR
Intervention: Ramosetron (0.3 mg after surgery)
Number of subjects: 165
Study 33630618 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior Therapy (BT)
Number of subjects: 219
Study 33630618 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 219
Study 32451528 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Awareness and Expression Therapy (EAET)
Number of subjects: 53
Study 32451528 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 53
Study 36267757 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized pharmaceutical care
Number of subjects: 118
Study 36267757 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 118
Study 33443770 — intervention group
Group type: EXPERIMENTAL
Intervention: Provocation condition
Number of subjects: 231
Study 33443770 — intervention group
Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 231
Study 35311346 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt substitute
Number of subjects: 20995
Study 33484336 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal cuff inflation to 60 mmHg
Number of subjects: 25
Study 33484336 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal cuff inflation to 60 mmHg
Number of subjects: 25
Study 33484336 — intervention group
Group type: COMPARATOR
Intervention: No cuff inflation (Control)
Number of subjects: 25
Study 32556539 — intervention group
Group type: EXPERIMENTAL
Intervention: Imeglimin 2250 mg
Number of subjects: 0
Study 32556539 — intervention group
Group type: EXPERIMENTAL
Intervention: Imeglimin 6000 mg
Number of subjects: 0
Study 32556539 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 0
Study 32556539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34240819 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aerobic exercise (150 min/week)
Number of subjects: 139
Study 34240819 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aerobic exercise (300 min/week)
Number of subjects: 139
Study 34240819 — intervention group
Group type: COMPARATOR
Intervention: Control (<75 min/week)
Number of subjects: 139
Study 34240819 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (for overweight women)
Number of subjects: 139
Study 34240819 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (for normal weight women)
Number of subjects: 139
Study 33573133 — intervention group
Group type: EXPERIMENTAL
Intervention: H2‐rich calcium powder (HCP) (1500 mg/day, containing 2.544 µg/day of H2)
Number of subjects: 18
Study 33573133 — intervention group
Group type: COMPARATOR
Intervention: H2‐depleted placebo (1500 mg/day)
Number of subjects: 18
Study 35358965 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) + Melatonin (MLT)
Number of subjects: 30
Study 35358965 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (sterile saline)
Number of subjects: 30
Study 34758017 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-dose ivermectin-based MDA (IVM-2)
Number of subjects: 3812
Study 34758017 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-dose ivermectin-based MDA (IVM-1)
Number of subjects: 3812
Study 34758017 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen and treat with topical permethrin 5% (SAT)
Number of subjects: 3812
Study 32556960 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids for 3 days
Number of subjects: 546
Study 32556960 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 days
Number of subjects: 546
Study 35475533 — intervention group
Group type: EXPERIMENTAL
Intervention: PRagmatic Explanatory Continuum Indicator Summary 2 (PRECIS‐2) tool
Number of subjects: 0
Study 35475533 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized study design types (parallel, crossover, factorial, stepped‐wedge)
Number of subjects: 0
Study 34781955 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐PRF+ (test, n = 15)
Number of subjects: 30
Study 34781955 — intervention group
Group type: COMPARATOR
Intervention: EMD (control, n = 15)
Number of subjects: 30
Study 33681741 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term mild hypothermia (34–35 °C for 5 days)
Number of subjects: 302
Study 33681741 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (37 °C)
Number of subjects: 302
Study 32063399 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-arm studies
Number of subjects: 0
Study 32063399 — intervention group
Group type: EXPERIMENTAL
Intervention: Externally controlled trials
Number of subjects: 0
Study 32063399 — intervention group
Group type: COMPARATOR
Intervention: External control
Number of subjects: 0
Study 32063399 — intervention group
Group type: EXPERIMENTAL
Intervention: Externally controlled studies
Number of subjects: 0
Study 33574421 — intervention group
Group type: COMPARATOR
Intervention: Control infant formula
Number of subjects: 290
Study 33574421 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational infant formulas with 0.8 g/100 ml scGOS/lcFOS and Bifidobacterium breve M‐16V at either 1 × 104 cfu/ml or 1 × 106 cfu/ml
Number of subjects: 290
Study 32232776 — intervention group
Group type: EXPERIMENTAL
Intervention: JuniorLEAP group therapy programme
Number of subjects: 32
Study 35862897 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (psychoeducation)
Number of subjects: 69
Study 35862897 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (computer)
Number of subjects: 69
Study 35862897 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (therapist-directed)
Number of subjects: 69
Study 35862897 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (integrated)
Number of subjects: 69
Study 35862897 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (all treatment arms)
Number of subjects: 69
Study 34659680 — intervention group
Group type: EXPERIMENTAL
Intervention: HBM education
Number of subjects: 268
Study 33447003 — intervention group
Group type: EXPERIMENTAL
Intervention: AEON™ Endostapler
Number of subjects: 60
Study 33447003 — intervention group
Group type: COMPARATOR
Intervention: Echelon Flex™ Powered Stapler
Number of subjects: 60
Study 35066944 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation (CBA)
Number of subjects: 150
Study 35066944 — intervention group
Group type: COMPARATOR
Intervention: Radio-frequency (RF) ablation using ablation index (AI) following the CLOSE protocol
Number of subjects: 150
Study 34688088 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned delivery
Number of subjects: 0
Study 34688088 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 0